Abstract |
Background and objectives: The aim of present study was to compare the treatment results of daily cisplatin (CDDP), weekly docetaxel (DOC) intra-arterial infusion chemotherapy combined with radiotherapy (DIACRT) regimen and weekly CDDP intra-arterial infusion chemotherapy combined with radiotherapy (WIACRT) for patients with tongue cancer. Materials and Methods: Between January 2007 and December 2016, a total of 11 patients treated with WIACRT and 45 patients treated with DIACRT were enrolled in the present study. In the DIACRT group, 25 patients had late T2, and 20 patients had T3. A total of nine patients had late T2 and two had T3 in WIACRT (p = NS). In DIACRT, the treatment schedule consisted of intra-arterial chemotherapy (DOC, total 60 mg/m²; CDDP, total 150 mg/m²) and daily concurrent radiotherapy (RT) (total, 60 Gy). In WIACRT, the treatment schedule consisted of intra-arterial chemotherapy (CDDP, total 360 mg/m²) and daily concurrent RT (total, 60 Gy). Results: The median follow-up periods for DIACRT and WIACRT were 61 and 66 months, respectively. The five-year local control (LC) and overall survival (OS) rate were 94.5% and 89.6% for the DIACRT group, and 60.6% and 63.6% for the WIACRT group, respectively. The LC rate and OS of the DIACRT group were significantly higher than those of the WIACRT group. As regards toxicities, no treatment-related deaths were observed during the follow-up periods in both groups. Conclusions: DIACRT was found to be feasible and effective for patients with tongue cancer and could become a new treatment modality.
|
Authors | Yuichiro Hayashi, Shuhei Minamiyama, Takashi Ohya, Masaki Iida, Toshinori Iwai, Toshiyuki Koizumi, Senri Oguri, Makoto Hirota, Mitomu Kioi, Masaharu Hata, Masataka Taguri, Kenji Mitsudo |
Journal | Medicina (Kaunas, Lithuania)
(Medicina (Kaunas))
Vol. 54
Issue 4
(Jul 30 2018)
ISSN: 1648-9144 [Electronic] Switzerland |
PMID | 30344283
(Publication Type: Comparative Study, Journal Article, Observational Study)
|
Chemical References |
- Antineoplastic Agents
- Docetaxel
- Cisplatin
|
Topics |
- Adult
- Aged
- Antineoplastic Agents
(administration & dosage, therapeutic use)
- Chemoradiotherapy
(methods)
- Cisplatin
(administration & dosage, therapeutic use)
- Cohort Studies
- Docetaxel
(administration & dosage, therapeutic use)
- Drug Administration Schedule
- Feasibility Studies
- Female
- Humans
- Infusions, Intra-Arterial
- Male
- Middle Aged
- Pilot Projects
- Retrospective Studies
- Survival Rate
- Tongue Neoplasms
(therapy)
- Treatment Outcome
|